Vaccine Study for Brain Tumors Targets Multiple Antigens

Armen Hareyan's picture
Advertisement

Brain Tumor

A new vaccine approach being studied at the University of Pittsburgh Cancer Institute (UPCI) is using multiple antigens to bring about an immune response to brain tumors, or gliomas

Advertisement